Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Metabolic Syndrome and Its Risk Factors Among Middle Aged Population of Iran, a Population Based Study Publisher Pubmed



Ebrahimi H1 ; Emamian MH2 ; Shariati M3 ; Hashemi H4 ; Fotouhi A5
Authors

Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews Published:2016


Abstract

Aims To determine the prevalence of metabolic syndrome (MS) and its risk factors in a middle-aged population in Iran. Methods The sample was 5190 individuals aged 40-64 years participated in the first phase of the Shahroud eye cohort study. Prevalence of MS was determined in terms of the age and sex. Other variables were evaluated by using simple and multiple logistic regression methods. Results The prevalence of MS was 10.88% in men, 13.03% in women and 12.14% in total. The prevalence proportion increased with increasing age. In multivariate logistic regression model, age (odds ratio (OR) = 1.06), education (OR = 0.98) and smoking (OR = 0.50), had significant effects on MS. In this model, gender, marital status and economic status had no significant effect on MS. Higher prevalence of obesity and overweight in non-smokers (79.9%) compare to smokers (47.4%, P < 0.001), indicated that the association of smoking and MS is confounded. Conclusions Despite the low prevalence of MS in this study, older age was associated with increased risk of developing MS and higher education was associated with decreased this risk, therefore health education, changing the lifestyle, and taking greater attention in elderly is needed in order to prevent the MS and its complications. © 2015 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Other Related Docs
9. Dyslipidemia and Its Risk Factors Among Urban Middle-Aged Iranians: A Population-Based Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2016)
10. Association Between the Dash Diet and Metabolic Syndrome Components in Iranian Adults, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)